Literature DB >> 24200287

Minor cognitive disturbances in X-linked spinal and bulbar muscular atrophy, Kennedy's disease.

Elisabeth Kasper1, Martin Wegrzyn, Ivo Marx, Christin Korp, Wolfram Kress, Reiner Benecke, Stefan J Teipel, Johannes Prudlo.   

Abstract

Spinal and bulbar muscular atrophy (SBMA), Kennedy's disease, is an adult-onset hereditary neurodegenerative disorder, associated predominantly with a lower motor neuron syndrome and eventually endocrine and sensory disturbances. In contrast to other motor neuron diseases such as amyotrophic lateral sclerosis (ALS), the impairment of cognition in SBMA is not well documented. We conducted a systematic cross-sectional neuropsychological study in order to investigate cognition in SBMA patients more thoroughly. We investigated 20 genetically proven SBMA patients compared to 20 age- and education-matched control subjects using a comprehensive neuropsychological test battery, measuring executive functioning, attention, memory and visuospatial abilities. The SBMA patients performed significantly worse than healthy controls in three sub-tests in the executive and attention domains. This low performance was in the working memory (digit span backward task), verbal fluency category (single letter fluency task) and memory storage capacity (digit span forward task). No disturbances were detected in other cognitive domains. The impairments were subclinical and not relevant to the patients' everyday functioning. In addition, no correlations were found between cognitive scores and the CAG repeat length. In conclusion, we found minor cognitive disturbances in patients with SBMA, which could indicate subtle frontal lobe dysfunction. These findings extend our neurobiological understanding of SBMA.

Entities:  

Mesh:

Year:  2013        PMID: 24200287     DOI: 10.3109/21678421.2013.837927

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Frontotemporal Degener        ISSN: 2167-8421            Impact factor:   4.092


  9 in total

Review 1.  Challenges in the Understanding and Treatment of Amyotrophic Lateral Sclerosis/Motor Neuron Disease.

Authors:  Jeffrey Rosenfeld; Michael J Strong
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

2.  Brain MRI shows white matter sparing in Kennedy's disease and slow-progressing lower motor neuron disease.

Authors:  Edoardo G Spinelli; Federica Agosta; Pilar M Ferraro; Giorgia Querin; Nilo Riva; Cinzia Bertolin; Ilaria Martinelli; Christian Lunetta; Andrea Fontana; Gianni Sorarù; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2019-03-28       Impact factor: 5.038

Review 3.  Learning disabilities in neuromuscular disorders: a springboard for adult life.

Authors:  Guja Astrea; Roberta Battini; Sara Lenzi; Silvia Frosini; Silvia Bonetti; Elena Moretti; Silvia Perazza; Filippo M Santorelli; Chiara Pecini
Journal:  Acta Myol       Date:  2016-10

Review 4.  Pharmacomodulation of microRNA Expression in Neurocognitive Diseases: Obstacles and Future Opportunities.

Authors:  Viorel Simion; Wissem Deraredj Nadim; Helene Benedetti; Chantal Pichon; Severine Morisset-Lopez; Patrick Baril
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

5.  The French national protocol for Kennedy's disease (SBMA): consensus diagnostic and management recommendations.

Authors:  Pierre-François Pradat; Emilien Bernard; Philippe Corcia; Philippe Couratier; Christel Jublanc; Giorgia Querin; Capucine Morélot Panzini; François Salachas; Christophe Vial; Karim Wahbi; Peter Bede; Claude Desnuelle
Journal:  Orphanet J Rare Dis       Date:  2020-04-10       Impact factor: 4.123

Review 6.  Empathy In Neurodegenerative Diseases: A Systematic Review.

Authors:  Emanuele Pick; Johann R Kleinbub; Stefania Mannarini; Arianna Palmieri
Journal:  Neuropsychiatr Dis Treat       Date:  2019-11-22       Impact factor: 2.570

Review 7.  Molecular Mechanisms and Therapeutics for SBMA/Kennedy's Disease.

Authors:  Frederick J Arnold; Diane E Merry
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

8.  Unimpaired Neuropsychological Performance and Enhanced Memory Recall in Patients with Sbma: A Large Sample Comparative Study.

Authors:  S Marcato; J R Kleinbub; G Querin; E Pick; I Martinelli; C Bertolin; S Cipolletta; E Pegoraro; G Sorarù; A Palmieri
Journal:  Sci Rep       Date:  2018-09-11       Impact factor: 4.379

Review 9.  Biomarkers of Spinal and Bulbar Muscle Atrophy (SBMA): A Comprehensive Review.

Authors:  Giorgia Querin; Peter Bede; Veronique Marchand-Pauvert; Pierre-Francois Pradat
Journal:  Front Neurol       Date:  2018-10-10       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.